leisure time -WSS

leisure time

author：leisure time 2025-10-03 00:39:33 - browse：64816

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — European regulators on Friday reiterated their view that an ALS treatment from Amylyx Pharmaceuticals should not be approved, likely dooming the drug’s chances for now.

A European Medicines Agency committee had initially recommended against approving the drug, known as Albrioza, in June. Friday’s confirmation of that position came after the company appealed the decision. While the European Commission officially decides whether to approve a new medicine, it almost always follows the committee’s guidance. The final decision is expected to be made before the end of the year.

The drug, which won approval last year in the United States and is marketed Relyvrio, is designed to slow the progression of the fatal neurological condition. In its pivotal trial, patients who received the drug over 24 weeks scored about two points better on a 48-point scale of symptoms than those who got a placebo, indicating the drug slowed disease progression.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Organ transplantation is at a crossroads. Major reform is needed

hotspot

WSS

A double vaccine crisis is endangering millions of children

7 of the most gruesome medical devices in history

What to know about Saharan dust affecting the US and how it can affect health

7 of the most gruesome medical devices in history

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Organ transplantation is at a crossroads. Major reform is needed

hotspot

leisure time

explore

Novavax promises a turnaround & Lilly roils the obesity market

White House launches permanent pandemic office

United colonoscopy coverage change 'may cost lives,' doctors say

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

The high cost of giving birth even with insurance

Caitlin Bernard's story shows physicians can't shy from advocacy

Walensky prepares to leave CDC — and Congress — behind

CDC backtracks, saying fully vaccinated people can go maskless indoors

Walensky prepares to leave CDC — and Congress — behind

New rules on organ donation and transplantation 'will bring chaos'

focus

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Elizabeth Warren probes abortion access

Caitlin Bernard's story shows physicians can't shy from advocacy

A double vaccine crisis is endangering millions of children

Body of missing toddler recovered in Delaware River days after flood: Police

Providers still hesitate to prescribe buprenorphine, study finds

hotspot

explore

hotspot

focus